Hsp90 is a heat stroke protein. It is common in all animals. Hsp90 inhibitors can be a therapeutic target and can help with cancer. However we are not sure of the components of aut992 so cannot comment if it would work. However many thesis around controlling hsp90 shows that it can help treat cancer. If we know what aut992 will target then we can gauge if it will work. This is an exciting area of cancer research and whoever cracks it will be able to save many lives.
5 Nov '14
help please continued
He comparing the potential to a company called hectares. In a nutshell he is confident behind the science and goes the target should work. If anyone has any knowledge please share
5 Nov '14
When btg was a fledgling I showed it to a friend (scientist) n he was excited about the pipeline n said it has great potential. At £1.80 I did not buy n what a miss. The same person recently showed me vernalis as he thinks the hsp90 target will work. Does anyone know what he means
5 Nov '14
RE: Help needed
I am afraid that even if you did find them they would be almost worthless due to fact that British biotech was found to have misled the public with its optimism of its two drugs at the time,it merged with Ribo targets then Vernalis and changed name to Vernalis,after the failure of the FDA to grant Frova permission to be used to treat menstrual migrane the shares tanked and where then massively diluted,it is a better company these days though.
22 Oct '14
I bought these shares when they were British Biotech many moons ago and cannot find my certificate, have got hold of capita and they can see no record, never cashed them in years ago because BB bombed. Anyone with an idea how to find the said share certificate please. Thank you in advance.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.